News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,675 Results
Type
Article (146)
Press Release (7529)
Section
Business (4911)
Career Advice (2)
Deals (592)
Drug Development (363)
FDA (78)
Job Trends (159)
News (5358)
Policy (142)
Tag
Academia (8)
Allergies (1)
Alliances (109)
ALS (2)
Alzheimer's disease (6)
Antibody-drug conjugate (ADC) (5)
Approvals (91)
Artificial intelligence (4)
ASCO (3)
Autoimmune disease (5)
Automation (1)
Bankruptcy (3)
Best Places to Work (157)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (5)
Breast cancer (21)
Cancer (90)
Cardiovascular disease (2)
Career advice (2)
CAR-T (1)
CDMO (1)
Cell therapy (4)
Cervical cancer (2)
Clinical research (396)
Collaboration (12)
Compensation (13)
Complete response letters (1)
COVID-19 (14)
C-suite (2)
Cystic fibrosis (3)
Data (107)
Depression (1)
Dermatology (1)
Diabetes (4)
Diagnostics (90)
Digital health (1)
Drug discovery (1)
Drug pricing (2)
Duchenne muscular dystrophy (5)
Earnings (5470)
Events (350)
Executive appointments (4)
FDA (177)
Fibrodysplasia Ossificans Progressiva (1)
Funding (15)
Gene editing (1)
Gene therapy (1)
GLP-1 (7)
Government (25)
Guidances (71)
Healthcare (293)
HIV (1)
Immunology and inflammation (3)
Immuno-oncology (1)
Indications (2)
Infectious disease (17)
Inflammatory bowel disease (2)
Influenza (1)
Intellectual property (5)
IPO (527)
Job creations (14)
Job search strategy (2)
Labor market (3)
Layoffs (8)
Legal (17)
Liver cancer (1)
Lung cancer (16)
Lymphoma (9)
Manufacturing (7)
MASH (1)
Medical device (316)
Medtech (323)
Mergers & acquisitions (80)
Metabolic disorders (12)
mRNA (1)
Multiple sclerosis (2)
NASH (1)
Netherlands (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (3)
Neuroscience (18)
NextGen: Class of 2026 (48)
Non-profit (9)
Obesity (8)
Opinion (1)
Ovarian cancer (2)
Pain (11)
Pancreatic cancer (3)
Parkinson's disease (1)
Patents (11)
Patient recruitment (3)
People (83)
Phase 1 (71)
Phase 2 (138)
Phase 3 (215)
Pipeline (462)
Postmarket research (13)
Preclinical (18)
Press Release (1)
Prostate cancer (3)
Radiopharmaceuticals (4)
Rare diseases (16)
Real estate (25)
Regulatory (141)
Reports (2)
Research institute (15)
Rett syndrome (1)
RSV (1)
Schizophrenia (1)
Series A (1)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (8)
Vaccines (11)
Venture capital (2)
Weight loss (1)
Women's health (3)
Date
Last 7 days (5)
Last 30 days (20)
Last 365 days (566)
2026 (400)
2025 (598)
2024 (668)
2023 (690)
2022 (820)
2021 (841)
2020 (696)
2019 (447)
2018 (405)
2017 (301)
2016 (179)
2015 (177)
2014 (162)
2013 (72)
2012 (96)
2011 (134)
2010 (173)
Location
Alabama (1)
Arizona (4)
Asia (367)
Australia (22)
California (352)
Canada (83)
China (21)
Colorado (13)
Connecticut (10)
Delaware (12)
Europe (806)
Florida (41)
Georgia (16)
Idaho (1)
Illinois (37)
India (1)
Indiana (28)
Japan (4)
Kansas (4)
Kentucky (2)
Louisiana (2)
Maine (4)
Maryland (44)
Massachusetts (193)
Michigan (5)
Minnesota (22)
Mississippi (1)
Missouri (3)
Montana (3)
Nevada (1)
New Hampshire (2)
New Jersey (97)
New York (75)
North Carolina (41)
Northern California (140)
Ohio (10)
Pennsylvania (48)
South America (9)
Southern California (198)
Tennessee (4)
Texas (31)
United States (1120)
Utah (11)
Virginia (4)
Washington D.C. (1)
Washington State (22)
West Virginia (1)
Wisconsin (5)
7,675 Results for "263".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
LifeMine raises $263M in mission to improve organ transplant aftercare
Patients who receive an organ transplant must take difficult immuno-suppressive medicines for the rest of their lives. LifeMine Therapeutics wants to offer a safer alternative.
August 6, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Antidiabetics Market Size to Reach USD 263.12 Billion by 2033
June 26, 2024
·
1 min read
Scaffold Technology Market Size to Reach Around USD 2.63 Bn by 2030
The global scaffold technology market was predicted to be USD 1.14 billion in 2021 and is anticipated to reach over USD 2.63 billion by 2030, growing at a CAGR of 9.68% from 2022 to 2030.
November 11, 2022
·
7 min read
Synthetic Biology Market Garner Growth 26.3% by 2030
According to the report, the global synthetic biology market was valued at US$ 4.96 Bn in 2018 and is projected to expand at a CAGR of 26.3% from 2019 to 2030.
March 31, 2022
·
6 min read
Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases
Ethris GmbH, a leading biotechnology company pioneering transformative messenger RNA therapeutics, announced that it has raised $26.3 Million in a Series B financing round led by Laureus Capital.
February 1, 2022
·
4 min read
Job Trends
Roche’s VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the VENTANA PD-L1 (SP263) Assay is available in countries accepting the CE mark as a companion diagnostic to identify non-small cell lung cancer (NSCLC) patients eligible for treatment with Libtayo® (cemiplimab), a PD-1 inhibitor therapy developed by Regeneron.
September 9, 2022
·
4 min read
Synthetic Biology Market is Projected to Expand at a CAGR of 26.3% from 2019 to 2027
According to the report, the global synthetic biology market was valued at US$ 4.96 Bn in 2018 and is projected to expand at a CAGR of 26.3% from 2019 to 2027
October 26, 2020
·
6 min read
Endoscopy Procedures Estimates Market to Garner US$ 263 Mn by 2032
Fact.MR – A Market research and competitive intelligence provider: The global endoscopy procedures estimates market was valued at US$ 223 Mn in 2021 and is expected to gain an important position in the market with a steady market size at a CAGR rate of 1.5% during the forecast period, 2022- 2032.
March 1, 2022
·
5 min read
Press Releases
Medexus Announces Strong Fiscal Q2 2025 Results
Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA* of $6.0 million Management to host conference call at 8:00 AM Eastern time on Friday, November 8, 2024
November 7, 2024
·
23 min read
BioMidwest
Gaming broadcasters celebrate $26.3 million raised for St. Jude Children’s Research Hospital, achieve 2020 fundraising goal early
During a record fundraising year, the gaming community is celebrating $26.3 million raised since the inception of St. Jude PLAY LIVE, the video game fundraising program that supports the lifesaving mission of St. Jude Children’s Research Hospital: Finding cures.
June 8, 2020
·
2 min read
1 of 768
Next
